HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

cyclo(prolyl-valyl)

structure in first source

Also Known As:

cyclo(L-Pro-L-Val); cyclo(Pro-Val)

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - Dipeptides: 945
      - cyclo(prolyl-valyl): 3

Experts

1.	Kang, Ki Sung: 1 article (07/2021)
2.	Kim, Ki Hyun: 1 article (07/2021)
3.	Lee, Dahae: 1 article (07/2021)
4.	Lee, Seoung Rak: 1 article (07/2021)
5.	Andersen, Jeanette H: 1 article (01/2020)
6.	Annang, Frederick: 1 article (01/2020)
7.	Deng, Hai: 1 article (01/2020)
8.	Ebel, Rainer: 1 article (01/2020)
9.	Fang, Qing: 1 article (01/2020)
10.	Kyeremeh, Kwaku: 1 article (01/2020)

Related Diseases

1.	Neoplasms (Cancer) 05/01/2006 - "However, three companion constituents, cyclo-Pro-Leu (5), cyclo-Pro-Phe (6), and cyclo-Pro-Val (7), did not inhibit cancer cell growth."
2.	Melanoma (Melanoma, Malignant) 01/22/2020 - "Preliminary screening of the metabolites from this strain resulted in the characterization of a new 2-alkyl-4-hydroxymethylfuran carboxamide (AHFA) 1 together with five known compounds, cyclo-(L-Pro-Gly) 2, cyclo-(L-Pro-L-Phe) 3, cyclo-(L-Pro-L-Val) 4, cyclo-(L-Leu-Hyp) 5, and deferoxamine E 6. AHFA 1, a methylenomycin (MMF) homolog, exhibited anti-proliferative activity (EC50 = 89.6 µM) against melanoma A2058 cell lines. "
3.	Inflammation (Inflammations) 07/29/2021 - "Taken together, these results indicate that cyclo(L-Pro-L-Val) (5) can be considered a potential therapeutic agent for the treatment of inflammation-associated disorders."

Related Drugs and Biologics

1.	Deferoxamine (Desferal)
2.	cyclo(prolyl-leucyl)
3.	prolylglycine
4.	cyclo-(L-Pro-L-Phe)